Breast-conserving radiation therapy: potential of inverse planning with intensity modulation

Radiology
Melanie C SmittA L Boyer

Abstract

To evaluate inverse planning with beam-intensity modulation in breast-conserving radiation therapy. A prototype inverse treatment-planning system was used in five patients with early-stage breast tumors. The prescription for the breast was 5,040 cGy in 180-cGy fractions, with the primary tumor site receiving 6,000 cGy in 214-cGy fractions. Isodose distributions from the prototype were compared section by section with those from conventional three-dimensional planning. The inverse planning system showed dose variation of 84%-98% to 111%-113% in the primary tumor site. For whole-breast irradiation, 95% of the target volume received at least 4,000 cGy. High-dose areas were adjacent to the primary site. Lower-dose areas were in the most medial part of the breast. Compared with the conventional system, target doses were similar. The volume of lung and heart that received high doses was smaller; however, larger lung and heart volumes received doses of less than 1,200 cGy. Intensity modulation may accomplish "concomitant boost" treatment. Acceptable dose gradients are achieved in the target volumes, with lower volumes of high-dose treatment in normal tissue. Plans that required comprehensive nodal radiation, in particular, were improv...Continue Reading

Citations

Feb 22, 2005·Medical Physics·David Djajaputra, Shidong Li
Jun 10, 2010·Medical Physics·Murat SurucuDaniel A Low
Mar 29, 2001·Radiology·M C SmittD R Goffinet
Jul 8, 2000·The British Journal of Radiology·C NuttingS Webb
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Frank A ViciniJohn Wong
Mar 17, 2004·Current Problems in Cancer·Natia EsiashviliJerome Landry
Apr 9, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Coen W HurkmansBen J Mijnheer
Aug 22, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Unnithan, R M Macklis
Nov 22, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jonas JohanssonBengt Glimelius
Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marco SchwarzEugène M F Damen
Jul 19, 2001·Australasian Physical & Engineering Sciences in Medicine·L OliverJ Drew
Sep 14, 2010·International Journal of Radiation Oncology, Biology, Physics·Reshma JagsiLori J Pierce
Feb 23, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Tarek HijalAlain Fourquet
May 5, 2009·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Junsheng CaoMary K Martel
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Shiva K DasJulian G Rosenman
Aug 15, 2006·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Indra J DasLawrence J Solin
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Coen W HurkmansJorien Cassee
Oct 5, 2016·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Juan-Francisco Calvo-OrtegaJoan Casals
Jul 26, 2018·The British Journal of Radiology·Yoshihiro UedaIndra J Das
Jun 25, 2004·Physics in Medicine and Biology·W XiongC M Ma
Mar 18, 2015·Technology in Cancer Research & Treatment·Andrzej P WojcieszynskiPoonam Yadav

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.